H-1B sponsorship profile: Ferring Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Ferring Pharmaceuticals, Inc filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 80% (8 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Ferring Pharmaceuticals, Inc’s H-1B petitions range from $175,000 at the low end to $219,870 at the high end, with a petition-weighted average of $185,197. That range reflects the mix of occupations the company sponsors, led by Med. Science Liaison - Reproductive Med. and Maternal Health (4 petitions at $175,000 avg), followed by Medical Science Liaison - Reproductive Medicine and Maternal and Principal, Medical Science Liaison. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Ferring Pharmaceuticals, Inc is headquartered in Parsippany, NJ under NAICS code 54171, and places H-1B workers across 2 states, most heavily in NJ, CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Ferring Pharmaceuticals, Inc ranks. By H-1B petition volume, Ferring Pharmaceuticals, Inc is #16,610 of 119,880 employers nationally and #1,387 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.